Jpmorgan Chase & CO Lensar, Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Lensar, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 256 shares of LNSR stock, worth $1,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
256
Previous 249
2.81%
Holding current value
$1,152
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LNSR
# of Institutions
42Shares Held
4.84MCall Options Held
1.5KPut Options Held
19.4K-
North Run Capital, LP Wellesley, MA1.1MShares$4.93 Million7.54% of portfolio
-
Park West Asset Management LLC Larkspur, CA1.09MShares$4.89 Million0.27% of portfolio
-
Dimensional Fund Advisors LP Austin, TX658KShares$2.96 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA433KShares$1.95 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA331KShares$1.49 Million0.02% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $49.6M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...